Repair & Recovery
Repair and recovery research compounds
An overview of the repair and recovery compounds in the catalog and the published literature around them.
Atlantic Longevity · 2026-09-24 · 2 min read
This category groups peptides most often studied in tissue-repair, wound-healing, and inflammation-related preclinical research. Several are frequently studied alongside one another because their research interest overlaps, but each is a distinct compound with its own literature.
BPC-157 and TB-500
BPC-157 is a synthetic peptide derived from a partial sequence of a protein found in human gastric juice, studied extensively in preclinical models of gastrointestinal and tissue-repair research. TB-500 is a synthetic fragment based on Thymosin Beta-4, an actin-binding peptide studied in the context of cell migration and tissue-repair signaling. The two are frequently studied together given their overlapping research area, and we carry them both separately and as a combined preparation.
GHK-Cu
GHK-Cu is a naturally occurring copper-binding tripeptide — glycyl-histidyl-lysine — and one of the more established compounds in dermal and wound-healing preclinical literature, with a published research history going back to the 1970s.
KPV
KPV is a short tripeptide, lysine-proline-valine, derived from the C-terminal sequence of alpha-MSH. It is studied in anti-inflammatory research contexts, notably in gut- and skin-inflammation model systems.
Thymosin Alpha-1
Thymosin Alpha-1 is a naturally occurring thymic peptide, studied extensively in immunology research for its role in modulating immune cell function.
Ara 290
Ara 290 is a non-hematopoietic analog of erythropoietin, studied for tissue-protective signaling through the innate repair receptor — a pathway distinct from erythropoietin's better-known role in red blood cell production.
GLOW
GLOW is a formulated blend rather than a single compound. Its current label and certificate of analysis on the product page state exactly what the lot contains; this overview does not restate a formulation.
What this overview does not cover
Consistent with our research-use-only status, nothing above states or implies a dose, an administration route, or an outcome in a person. Each entry describes a research area a compound appears in, not a result it produces.